Ciro Celsa

Ciro Celsa is a Researcher at the University of Palermo within the Department of Health Promotion, Maternal and Child, Internal Medicine, and Specialist Excellence 'G. D'Alessandro' under the School of Medicine and Surgery. His clinical and research focus centers on hepatocellular carcinoma (HCC) management, particularly systemic therapies, immunotherapy combinations, and real-world treatment outcomes.

• Role: Researcher in Internal Medicine and HCC Specialist
• Key Collaborations: HCC Sicily Multidisciplinary Network

Research Interests include:

• Clinical application of immunotherapy (e.g., Atezolizumab, Bevacizumab, Lenvatinib)
• Survival analysis and prognostic modeling in advanced HCC
• Hepatic decompensation as a mortality driver
• Comparative effectiveness of minimally invasive treatments
• Integration of artificial intelligence in HCC management
• Role of metabolic and autoimmune factors in liver cancer progression

Article Trends reveal a focus on frontline systemic therapies for HCC, risk stratification tools (ALBI Grade), drug combinations (anti-PD-L1 + anti-VEGF), and real-world validation of clinical trial results through large-scale meta-analyses and cohort studies.

Labs & Teams: Actively involved with the HCC Sicily Multidisciplinary Network, contributing to regional and international studies on HCC epidemiology and treatment optimization.